Osteosarcoma — Trials

Osteosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

349 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 99
Recruiting: 58
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01882231	Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma	terminated	N/A	6	Vanderbilt-Ingram Cancer CenterOTHER	1	May 8, 2017	clinicaltrials
NCT00673179	Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy	terminated	N/A	7	M.D. Anderson Cancer CenterOTHER	1	Sep 10, 2014	clinicaltrials